Metformin Therapy for Patients With COVID-19 Without Obesity-Reply.
Publication
, Journal Article
Bramante, CT; Boulware, DR; Naggie, S
Published in: JAMA Intern Med
March 1, 2026
Duke Scholars
Published In
JAMA Intern Med
DOI
EISSN
2168-6114
Publication Date
March 1, 2026
Volume
186
Issue
3
Start / End Page
385 / 386
Location
United States
Related Subject Headings
- 4203 Health services and systems
- 3202 Clinical sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Bramante, C. T., Boulware, D. R., & Naggie, S. (2026). Metformin Therapy for Patients With COVID-19 Without Obesity-Reply. JAMA Intern Med, 186(3), 385–386. https://doi.org/10.1001/jamainternmed.2025.6796
Bramante, Carolyn T., David R. Boulware, and Susanna Naggie. “Metformin Therapy for Patients With COVID-19 Without Obesity-Reply.” JAMA Intern Med 186, no. 3 (March 1, 2026): 385–86. https://doi.org/10.1001/jamainternmed.2025.6796.
Bramante CT, Boulware DR, Naggie S. Metformin Therapy for Patients With COVID-19 Without Obesity-Reply. JAMA Intern Med. 2026 Mar 1;186(3):385–6.
Bramante, Carolyn T., et al. “Metformin Therapy for Patients With COVID-19 Without Obesity-Reply.” JAMA Intern Med, vol. 186, no. 3, Mar. 2026, pp. 385–86. Pubmed, doi:10.1001/jamainternmed.2025.6796.
Bramante CT, Boulware DR, Naggie S. Metformin Therapy for Patients With COVID-19 Without Obesity-Reply. JAMA Intern Med. 2026 Mar 1;186(3):385–386.
Published In
JAMA Intern Med
DOI
EISSN
2168-6114
Publication Date
March 1, 2026
Volume
186
Issue
3
Start / End Page
385 / 386
Location
United States
Related Subject Headings
- 4203 Health services and systems
- 3202 Clinical sciences